As of January 22, 2025, MeiraGTx (MGTX) has a market cap of $0.47 billion USD. According to our data, MeiraGTx is ranked No.6190 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.47 B |
-0.74%
|
Dec 31, 2024 | $0.48 B |
-13.25%
|
Dec 29, 2023 | $0.55 B |
7.67%
|
Dec 30, 2022 | $0.51 B |
-72.54%
|
Dec 31, 2021 | $1.86 B |
56.80%
|
Dec 31, 2020 | $1.18 B |
-24.38%
|
Dec 31, 2019 | $1.56 B |
107.68%
|
Dec 31, 2018 | $0.75 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$77.49 M |
-0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.38 B |
0.000 M
|
USA
|
Adverum Biotechnologies
ADVM
|
$93.20 M |
0.000 M
|
USA
|
Voyager Therapeutics
VYGR
|
$0.30 B |
-0.000 M
|
USA
|
uniQure
QURE
|
$0.82 B |
0.000 M
|
Netherlands
|
Generation Bio
GBIO
|
$63.79 M |
0.000 M
|
USA
|
4D Molecular Therapeutics
FDMT
|
$0.21 B |
0.000 M
|
USA
|
Market Cap | = | MGTX Stock Price | * | MGTX Shares Outstanding |
= | $6.05 | * | 78.15 M | |
= | $0.47 B |